Sonida Senior Living, Inc. SNDA R2KR3KPHARMA
Company Overview
Sonida Senior Living, Inc. owns and operates senior housing communities in the United States. The company provides independent living services, which include daily meals, transportation, social and recreational activities, laundry, housekeeping, and 24-hour staffing; and access to health screenings, periodic special services, and dietary and similar programs, as well as exercise and fitness classes. It offers assisted living services consist of personal care services, such as assistance with activities of daily living, including ambulation, bathing, dressing, eating, grooming, personal hygiene, and monitoring or assistance with medications; support services, such as meals, assistance with social and recreational activities, laundry, general housekeeping, maintenance, and transportation services; and supplemental services, which include extra transportation, personal maintenance, and extra laundry services, as well as special care services for residents with various forms of dementia. In addition, it offers memory care services; and home care services through third-party providers, such as customized physician, dentistry, podiatry, and other health-related rehabilitation and therapy services. Further, it provides respite care and temporary care and therapy programs. The company was formerly known as Capital Senior Living Corporation and changed its name to Sonida Senior Living, Inc. in November 2021. Sonida Senior Living, Inc. was founded in 1990 and is based in Dallas, Texas.
Why Investors Should Care
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $381.14M (+25.2% YoY); net profit $-70.78M.
- Trailing 12 Months Year-on-year growth — revenue +38.5%.
- 5-Year Trend Long-term compounding — revenue CAGR 4.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 4.38% |
| 1 Year: | 38.50% |
Stock Price Performance
| 1 Year: | +45.07% |
| 6 Months: | +2.87% |
| 3 Months: | +9.63% |
| 1 Month: | -6.62% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMAAbove
- RSI (14)42.11 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SNDA Sonida Senior Living, Inc. R2KR3KPHARMA | 37.69 | -6.46 | $1.78B | 0.00% | 9.28% | -20.08% | 4.38% | - |
| 2 | LLY Eli Lilly and Company SPXR3KPHARMA | 1,149.36 | 38.57 | $1.02T | 0.58% | - | 102.29% | 7.20% | 11.41% |
| 3 | JNJ Johnson & Johnson SPXR3KPHARMA | 275.23 | 31.97 | $663.28B | 2.09% | 14.88% | 25.74% | 2.43% | 4.76% |
| 4 | ABBV AbbVie Inc. SPXR3KPHARMA | 256.46 | 72.45 | $453.19B | 2.84% | 10.47% | -129.24% | 1.75% | -29.06% |
| 5 | MRK Merck & Co., Inc. SPXR3KPHARMA | 150.33 | 120.26 | $371.29B | 2.65% | - | 34.70% | 5.64% | 10.01% |
| 6 | UNH UnitedHealth Group Incorporated SPXR3KPHARMA | 397.14 | 25.54 | $356.47B | 2.33% | 9.74% | 14.15% | 10.40% | 5.43% |
| 7 | NVS Novartis AG PHARMA | 159.99 | 24.20 | $304.10B | 3.03% | 21.09% | 30.35% | 9.25% | 26.22% |
| 8 | AZN AstraZeneca PLC NDXPHARMA | 162.70 | 24.36 | $252.33B | 1.98% | 15.97% | 21.96% | 9.82% | 45.96% |
| 9 | AMGN Amgen Inc. NDXSPXR3KPHARMA | 437.23 | 27.14 | $235.98B | 2.49% | 13.95% | 91.47% | 5.51% | 5.55% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | 115.99M | 116.72M | 117.32M | 116.97M | 114.64M | 114.63M | 115.65M | 115.10M | 114.18M | 113.13M | 111.11M | 108.69M | 106.13M | 101.48M | 96.05M | 61.65M | 57.54M | 57.92M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income | - | 3.72M | 3.68M | 5.68M | - | 4.15M | 5.79M | 3.69M | - | -9.61M | 4.69M | 4.51M | - | 5.39M | 3.64M | 1.70M | - | 1.97M | 203.00K | -8.11M | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.91M | - | - | 20.14M | - | - | - |
| Net Income | -3.90M | -6.04M | -5.17M | 2.87M | -5.95M | -5.98M | -4.45M | -7.08M | -10.51M | -21.84M | -7.83M | -8.13M | -6.36M | -7.16M | -9.06M | -11.09M | -26.29M | -12.98M | -12.53M | -20.73M | 10.22M | -47.18M | -12.75M | -214.96M | 38.84M | 49.08M | 36.51M | -16.68M | -7.41M | -13.74M | 24.14M | -12.21M | -18.41M | 27.02M | -9.82M | -13.76M | -12.53M | -1.56M | -26.91M | -41.23M |
| Diluted EPS | -0.13 | -0.21 | -0.18 | 0.10 | -0.21 | -0.21 | -0.15 | -0.24 | -0.36 | -750.00 | -270.00 | -280.00 | -220.00 | -0.24 | -0.30 | -0.37 | -0.88 | -0.43 | -0.41 | -0.68 | 0.34 | -23.28 | -6.25 | -104.91 | 18.80 | 23.49 | 17.48 | -2.81 | -1.34 | -2.34 | 2.76 | -2.11 | -2.79 | 2.16 | -0.86 | -0.98 | -0.77 | -0.16 | -1.56 | -2.39 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 191.99M | 211.93M | 263.50M | 310.54M | 350.36M | 383.93M | 412.18M | 447.45M | 467.00M | 460.02M | 447.10M | 383.86M | 234.72M | 238.43M | 255.32M | 304.33M | 381.14M |
| Operating Income | 16.61M | 18.52M | 17.91M | 13.65M | 11.25M | 13.90M | 18.84M | 14.39M | 7.84M | 7.60M | -14.69M | - | - | - | 57.90M | 68.67M | - |
| Net Income | 2.76M | 4.25M | 3.02M | -3.12M | -16.50M | -24.13M | -14.28M | -28.02M | -44.17M | -53.60M | -36.03M | -295.37M | 125.61M | -54.40M | -21.11M | -2.06M | -70.78M |
| Diluted EPS | 0.10 | 0.16 | 0.11 | -0.11 | -0.58 | -0.83 | -0.50 | -0.97 | -1.50 | -26.97 | -17.87 | -144.08 | 37.92 | -9.27 | -3.85 | -0.54 | -4.22 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 382.78M | 462.33M | 636.94M | 745.55M | 891.37M | 1.02B | 1.15B | 1.18B | 1.15B | 1.27B | 702.83M | 728.55M | 661.27M | 621.46M | 841.92M | 844.85M |
| Total Equity | 155.15M | 158.13M | 163.82M | 169.14M | 168.59M | 157.95M | 141.17M | 135.75M | 116.92M | 80.43M | 35.27M | 14.38M | -279.26M | -46.81M | -101.71M | -115.09M | 71.78M | -11.00K |
| Cash & Equivalents | 25.88M | 28.97M | 31.25M | 22.28M | 18.74M | 13.61M | 39.21M | 56.09M | 34.03M | 17.65M | 31.31M | 23.98M | 17.89M | 78.69M | 16.91M | 4.08M | 16.99M | 11.01M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | 604.73M | 613.34M | 625.00M | 587.10M | 635.90M | 682.45M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - | - | - | 982.10M | 734.11M | 719.43M | 688.01M | 712.31M | 788.59M |
| Current Liabilities | - | - | 32.40M | 40.21M | 62.15M | 58.70M | 99.46M | 70.54M | 81.39M | 87.00M | 85.03M | 129.03M | 373.12M | 120.48M | 94.32M | 100.86M | 75.61M | 105.13M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 19.64M | 15.55M | 14.08M | 46.40M | 42.64M | 52.28M | 55.59M | 36.87M | 5.23M | -6.79M | -28.80M | -2.58M | 10.68M | -1.78M | 24.36M |
| Investing Cash Flow | -7.30M | -5.28M | -77.44M | -190.62M | -162.30M | -201.05M | -124.94M | -21.91M | 47.78M | 8.51M | -10.44M | -36.90M | -16.56M | -208.92M | -70.69M |
| Financing Cash Flow | -9.24M | -7.99M | 54.39M | 140.67M | 114.53M | 126.85M | 53.05M | -1.67M | -60.26M | -15.92M | 99.42M | -22.65M | -7.11M | 232.04M | 37.51M |
| Capital Expenditure | - | - | - | - | - | - | - | - | - | - | -10.44M | -24.56M | -17.94M | -25.17M | -33.28M |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - | -39.24M | -27.14M | -7.25M | -26.95M | -8.92M |
| Share Buybacks | 934.00K | - | - | - | - | 2.50M | - | - | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | 8.7% | 8.7% | 6.8% | 4.4% | 3.2% | 3.6% | 4.6% | 3.2% | 1.7% | 1.7% | -3.3% | - | - | - | 22.7% | 22.6% | - |
| Net Margin % | 1.4% | 2.0% | 1.1% | -1.0% | -4.7% | -6.3% | -3.5% | -6.3% | -9.5% | -11.7% | -8.1% | -76.9% | 53.5% | -22.8% | -8.3% | -0.7% | -18.6% |
| ROE % | 1.7% | 2.6% | 1.8% | -1.9% | -10.4% | -17.1% | -10.5% | -24.0% | -54.9% | -152.0% | -250.6% | 105.8% | -268.3% | 53.5% | 18.3% | -2.9% | 643,445.5% |
| ROCE % | - | 5.3% | 4.2% | 2.4% | 1.6% | 1.8% | 2.0% | 1.4% | 0.7% | 0.7% | -1.3% | - | - | - | 11.1% | 9.0% | - |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Conversant Capital LLC | 30.40% | 14.61M | $547.14M |
| 2 | Capital International Investors | 6.85% | 3.29M | $123.31M |
| 3 | Pertento Partners LLP | 4.94% | 2.38M | $88.99M |
| 4 | Blackrock Inc. | 4.62% | 2.22M | $83.11M |
| 5 | Irenic Capital Management LP | 3.96% | 1.90M | $71.31M |
| 6 | Vanguard Capital Management LLC | 2.68% | 1.29M | $48.29M |
| 7 | Geode Capital Management, LLC | 1.55% | 742.70K | $27.82M |
| 8 | Tyro Capital Management LLC | 1.31% | 628.15K | $23.53M |
| 9 | State Street Corporation | 1.29% | 618.50K | $23.17M |
| 10 | Nuveen, LLC | 1.19% | 571.64K | $21.41M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for SNDA
Sonida Senior Living (SNDA) On Deal Expansion Hopes Is The Stock A Bargain Or Priced In - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQY2kwSWtHSS1VdE5IUDJjN0F6SmdxeERQaHJlcmlzel8zckJFRmtTMkdpR0Rub21nWEl2NEtpQkVldTItOG1IbFlOekhnNUZPeUhpX2pnaWJpM01URFI4Ulp4anljQnlfNElsVFhFYUVFQ0tGRnZZeWhMNmk0VmFNQTlvbFFxNmx2ZVp3UG…
Sonida Senior Living Stock: Macro Drivers Fuel Growth (NYSE:SNDA) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMiqgFBVV95cUxQZE1QMzNGX1BPSGlfQkdyWVMtQ3pWVDdIWHpNMVo0WjRKOXhQUW5GdDZMbGtKcnFHUjdBSklzVHZpTkhKbUZkazZRTHFBUTVseXNFam9PdFNiY0VmLTdHSFlFLUlETGdpeUU1ekZzYmduLVB1cnlvVW5POG9UUUJQWUZtS3VBZzJibjZDQV…
Bank of New York Mellon Corp Purchases Shares of 88,940 Sonida Senior Living, Inc. $SNDA - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMi3gFBVV95cUxQNVdvRGFlbVJxYzR5TWhfZXZyNVg4Xy1XVk9pOXYyeE03c2p0MDJadkF5LTkzVENIYVBLeTU4STNNSEVpQ3ExVWdZMnRuelB0TXBsV21JZlJYYk5EYWlXMS1BcEZfeGc1WjZFOXlSU01SSGdPR2VaODhTSEFXOUw2VURQX2ZFeEl4V1V6Wk…
100K Sonida Senior Living (NYSE: SNDA) shares leave insider’s control without a sale - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxOZ1paUXVuUGhYU0RaVEQ3UWNhNkRhOWVwMVhVN1AwSjBDeFl6ZEFBa2JVNTlxbnRESXdYb0p1VEFSeUNGbFdOUllXS0ZTU05DcnZwZklxenpMdFd4d05HclBWOW82bVY1ejI3R3k5V2NFRnhSZENrRUlERG5RM1QxNnctb0tmbl92U2FvaU…
Why Sonida Senior Living (SNDA) Is Getting Attention Today - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxQaWdYT1NpVHMwdzU0Z0xFTlhKX0xOdkttXzh4VjBBWVc1NC0xWGd4Q2RkMkJDdVBiNUNZVU1ndklQcUlYUUpuRnA1dUQ5SmoyVjZTT3NRdU5mUmk0bkVXcG8yc3ZOZXRsN3JQaG5ONV8xaXhPUG11cjZEallEdlNyUGpDeGd6RjR2LWJ3cn…
Sonida Senior Living Shares Rise After Baird Upgrade - Moomoo
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOcUI2Ql9RdE55eFowV0poN3NFaTBZU19QQzkxM05kdUNkdW1KdnNfV2NWdjFwNUhYNE1nODJ0RXZ3YUVuNnlBQVE3ZERmMHd4NXNnTTJGYW5OMkdqcGk2eDRtZjQwcXFhbzhMUTE2dlNRdV9qV3JOVTI0ei1KZWVtWXpsejRhMk9Uamk5aG…
SNDA — Frequently Asked Questions
What is the current share price of Sonida Senior Living, Inc. (SNDA)?
As of 2026-09-07 16:24 PDT, Sonida Senior Living, Inc. (SNDA) trades at $37.69 on NYSE. Its 52-week range is $25.27 to $43.07.
What is the market capitalisation of SNDA?
Sonida Senior Living, Inc. (SNDA) has a market capitalisation of $1.78B on NYSE.
What is the P/E ratio of SNDA?
SNDA trades at a trailing price-to-earnings (P/E) ratio of -6.46. The industry average P/E is 25.17. Its price-to-book (P/B) ratio is 2.13.
What is the return on equity (ROE) of SNDA?
SNDA has a return on equity (ROE) of -20.08%. Its return on capital employed (ROCE) is 9.28%.
Is SNDA a good stock to buy?
This page provides a data-driven analysis of Sonida Senior Living, Inc. (SNDA), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.